Relmada Therapeutics, Inc. RLMD
4.14 USD +0.24 (+6.15%)
At closeNov 10, 2026, 4:34 AM EST
3.97 -0.17 -4.11%
Pre-market · Nov 10, 4:34 AM ET
3.91 Day range 4.18
2.65 52-week range 8.00
- YTD
- -14.29%
- 1 year
- +56.23%
News
globenewswire.com Relmada Therapeutics to Participate at the Jefferies Global Healthcare Conference in London CORAL GABLES, Fla., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for…
globenewswire.com Relmada Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026 CORAL GABLES, Fla., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for…
benzinga.com Full Transcript: Relmada Therapeutics Q2 2026 Earnings Call Relmada Therapeutics (NASDAQ:RLMD) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. Benzinga APIs provide…